帶因者篩檢市場規模、佔有率、成長分析，按檢測類型、按疾病類型、按條件、按技術、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

2023 年全球帶因者篩檢市場規模價值為 25 億美元，預計將從 2024 年的 28.3 億美元成長到 2032 年的 76.3 億美元，預測期內（2025-2032 年）的複合年成長率為 13.2%。

隨著遺傳病患病率不斷上升以及對預防性醫療保健的日益重視，全球帶因者篩檢市場預計將出現成長。基因組技術的進步以及人們對囊腫纖維化、泰-薩克斯病和鐮狀細胞性貧血等疾病的認知不斷提高，預計將在未來幾年增加攜帶者篩檢的採用。此外，基因檢測管道的改善和優惠的報銷政策也為產業相關人員創造了新的機會。然而，缺乏標準化、新興市場認知度低、結果解釋複雜、先進測試技術高成本挑戰可能會阻礙市場向 2031 年擴張。整體而言，創新環境已經成熟，但相關人員必須克服這些障礙，才能利用成長機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

攜帶者篩檢市場規模（按測試類型分類）

• 市場概況
• 分子篩檢測試
• 生化篩檢測試

攜帶者篩檢市場規模（依疾病類型）

• 市場概況
• 囊腫纖維化
• 戴-薩克斯病
• 高雪氏症
• 鐮狀細胞性貧血症
• 脊髓性肌肉萎縮
• 其他體染色體隱性遺傳疾病

攜帶者篩檢市場規模（依疾病狀況）

• 市場概況
• 肺部疾病
• 血液系統疾病
• 神經系統疾病
• 其他

攜帶者篩檢市場規模（依技術分類）

• 市場概況
• DNA序列分析
• 聚合酵素鏈鎖反應
• 微陣列
• 其他

按最終用戶分類的帶因者篩檢市場規模

• 市場概況
• 醫院
• 參考實驗室
• 診所
• 其他

攜帶者篩檢市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Natera, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Quest Diagnostics Incorporated（USA）
• Invitae Corporation（USA）
• PerkinElmer, Inc.（USA）
• Fulgent Genetics（USA）
• Agilent Technologies, Inc.（USA）
• Genomics England（UK）
• Centogene AG（Germany）
• Integrated DNA Technologies, Inc.（IDT）（USA）
• BGI Genomics（China）
• Ambry Genetics Corporation（USA）
• DNA Genotek Inc.（Canada）
• GeneDx, Inc.（USA）
• MedGenome Labs Pvt. Ltd.（India）

結論和建議

Global Carrier Screening Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 7.63 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).

The global carrier screening market is poised for growth, driven by the rising incidence of genetic diseases and an increasing focus on preventive healthcare. Advancements in genomic technologies and heightened awareness of disorders like cystic fibrosis, Tay-Sachs, and sickle cell anemia are expected to enhance the adoption of carrier screening in the coming years. Furthermore, improved accessibility to genetic testing and favorable reimbursement policies present new opportunities for industry players. However, challenges such as a lack of standardization, limited awareness in emerging markets, complexities in result interpretation, and the high costs associated with advanced testing technologies may hinder market progression through 2031. Overall, the landscape is ripe for innovation, but stakeholders must navigate these hurdles to capitalize on growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The growing prevalence of genetic disorders acts as a significant catalyst for the Global Carrier Screening market. As more individuals and families become aware of the risks associated with hereditary conditions, the demand for carrier screening tests rises. This heightened awareness drives healthcare providers to prioritize genetic screening as a preventive measure, allowing for informed decision-making and risk assessment. Furthermore, advancements in genetic testing technologies and increasing accessibility to these services contribute to the market's expansion. Ultimately, the high incidence of genetic disorders emphasizes the importance of carrier screening, fostering growth and innovation within the industry.

Restraints in the Global Carrier Screening Market

One of the significant challenges facing the global carrier screening market is the lack of standardization in screening panels. This issue can lead to inconsistencies in test results and interpretations, which may cause confusion among healthcare providers and patients alike. The variability in testing methodologies and panel compositions across different laboratories can hinder the reliability and comparability of results. Additionally, the absence of a unified framework may create barriers to widespread adoption of carrier screening, as stakeholders may be uncertain about the effectiveness and relevance of various screening options. Addressing this lack of standardization is crucial for the market's growth and acceptance.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is witnessing a significant trend towards the integration of digital health solutions, which is poised to enhance patient engagement and streamline the screening process. As companies increasingly adopt digital platforms, the convenience and accessibility of carrier screening services are expected to attract a broader demographic, ultimately driving market growth. This convergence fosters a more personalized healthcare experience, encouraging more individuals to participate in screening initiatives. By leveraging technology, companies can not only expand their operational reach but also refine their service offerings, positioning themselves favorably in a rapidly evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Carrier Screening Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular Screening Test
• Biochemical Screening Test

Global Carrier Screening Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Other Autosomal Recessive Genetic Disorders

Global Carrier Screening Market Size by Medical Condition & CAGR (2025-2032)

• Market Overview
• Pulmonary Conditions
• Hematological Conditions
• Neurological Conditions
• Others

Global Carrier Screening Market Size by Technology & CAGR (2025-2032)

• Market Overview
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Others

Global Carrier Screening Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Reference Laboratories
• Physician Offices and Clinics
• Others

Global Carrier Screening Market Size & CAGR (2025-2032)

• North America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • US
  • Canada
• Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomics England (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centogene AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambry Genetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Genotek Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations